These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30106761)

  • 41. Soft-Tissue Augmentation With Hyaluronic Acid Filler for Labia Majora and Mons Pubis.
    Hexsel D; DalʼForno T; Caspary P; Hexsel CL
    Dermatol Surg; 2016 Jul; 42(7):911-4. PubMed ID: 27227470
    [No Abstract]   [Full Text] [Related]  

  • 42. Avoiding the "danger zones" when injecting dermal fillers and volume enhancers.
    Brennan C
    Plast Surg Nurs; 2014; 34(3):108-11; quiz 112-3. PubMed ID: 25188847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of impending necrosis associated with soft tissue filler injections.
    Dayan SH; Arkins JP; Mathison CC
    J Drugs Dermatol; 2011 Sep; 10(9):1007-12. PubMed ID: 22052269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Multi-Center, Open-Label, Prospective Study of Cannula Injection of Small-Particle Hyaluronic Acid Plus Lidocaine (SPHAL) for Lip Augmentation.
    Chopra R; Graivier M; Fabi S; Nestor M; Meuse P; Mashburn J
    J Drugs Dermatol; 2018 Jan; 17(1):10-16. PubMed ID: 29320583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on hyaluronic acid fillers for facial rejuvenation.
    Mansouri Y; Goldenberg G
    Cutis; 2015 Aug; 96(2):85-8. PubMed ID: 26367746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of early nodules after injection of hyaluronic acid filler.
    Lee SJ; Seok J; Park KY; Kim BJ; Kim YK
    J Am Acad Dermatol; 2017 Jul; 77(1):e5-e6. PubMed ID: 28619575
    [No Abstract]   [Full Text] [Related]  

  • 47. [Lidocaine-containing hyaluronic acid filler on a CPM® basis for lip augmentation : Experience from clinical practice].
    Fischer T; Sattler G; Gauglitz G
    Hautarzt; 2016 Jun; 67(6):472-8. PubMed ID: 27052527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Retrobulbar Hyaluronidase in Filler-Associated Blindness: Evaluation of Fundus Perfusion and Electroretinogram Readings in an Animal Model.
    Hwang CJ; Mustak H; Gupta AA; Ramos RM; Goldberg RA; Duckwiler GR
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):33-37. PubMed ID: 29877958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse reactions to injectable soft tissue fillers: memorable cases and their clinico-pathological overview.
    Lee SK; Kim SM; Cho SH; Lee JD; Kim HS
    J Cosmet Laser Ther; 2015 Apr; 17(2):102-8. PubMed ID: 25260141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary on: Efficacy of Retrobulbar Hyaluronidase Injection for Vision Loss Resulting from Hyaluronic Acid Filler Embolization.
    DeLorenzi C
    Aesthet Surg J; 2017 Dec; 38(1):23-27. PubMed ID: 29244093
    [No Abstract]   [Full Text] [Related]  

  • 51. Durability of Three Different Types of Hyaluronic Acid Fillers in Skin: Are There Differences Among Biphasic, Monophasic Monodensified, and Monophasic Polydensified Products?
    da Costa A; Biccigo DGZ; de Souza Weimann ET; Mercadante LM; Oliveira PRG; Prebianchi SB; Abdalla BMZ
    Aesthet Surg J; 2017 May; 37(5):573-581. PubMed ID: 27923810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. External Compression Versus Intravascular Injection: A Mechanistic Animal Model of Filler-Induced Tissue Ischemia.
    Chang SH; Yousefi S; Qin J; Tarbet K; Dziennis S; Wang R; Chappell MC
    Ophthalmic Plast Reconstr Surg; 2016; 32(4):261-6. PubMed ID: 26125287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
    Hwang CJ; Perry JD
    Plast Reconstr Surg; 2020 Mar; 145(3):658e-660e. PubMed ID: 32097351
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of AccuVein™ for preventing complications from accidental venipuncture when administering dermal filler injections.
    Lee GS
    J Cosmet Laser Ther; 2015 Feb; 17(1):55-6. PubMed ID: 25260136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyaluron Filler Containing Lidocaine on a CPM Basis for Lip Augmentation: Reports from Practical Experience.
    Fischer TC; Sattler G; Gauglitz GG
    Facial Plast Surg; 2016 Jun; 32(3):283-8. PubMed ID: 27248026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Not Available].
    Meier T; Kirchhoff J; Andreoni C; Pfaltz M; Bornstein MM
    Swiss Dent J; 2017; 127(11):964-965. PubMed ID: 29199773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discussion: Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
    Fagien S
    Plast Reconstr Surg; 2019 Jul; 144(1):144-146. PubMed ID: 31246818
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply: Effectiveness of Retrobulbar Hyaluronidase Injection in an Iatrogenic Blindness Rabbit Model Using Hyaluronic Acid Filler Injection.
    Lee W; Yang EJ
    Plast Reconstr Surg; 2020 Mar; 145(3):659e-661e. PubMed ID: 32097352
    [No Abstract]   [Full Text] [Related]  

  • 60. A Physical Argument Against the Use of Small Syringes for Hyaluronic Acid Filler Injections.
    Friedmann DP; Tran J; Dorland JM
    Dermatol Surg; 2020 Jul; 46(7):993-994. PubMed ID: 31567607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.